Cargando…
Predictors of humoral response to SARS-CoV-2 mRNA vaccine BNT162b2 in patients receiving maintenance dialysis
OBJECTIVE: Patients on dialysis are at high risk for severe COVID-19 and associated morbidity and mortality. We examined the humoral response to SARS-CoV-2 mRNA vaccine BNT162b2 in a maintenance dialysis population. DESIGN: Single-center cohort study. SETTING AND PARTICIPANTS: Adult maintenance dial...
Autores principales: | Li, Tingting, Gandra, Sumanth, Reske, Kimberly A., Olsen, Margaret A., Bommarito, Silvana, Miller, Candace, Hock, Karl G., Ballman, Claire A., Su, Christina, Le Dang, Na, Kwon, Jennie H., Warren, David K., Fraser, Victoria J., Farnsworth, Christopher W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615013/ https://www.ncbi.nlm.nih.gov/pubmed/36310813 http://dx.doi.org/10.1017/ash.2022.31 |
Ejemplares similares
-
Longitudinal analysis of risk factors associated with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among hemodialysis patients and healthcare personnel in outpatient hemodialysis centers
por: Gandra, Sumanth, et al.
Publicado: (2022) -
Longevity of Humoral Response Six Months Following BNT162b2 Vaccine in Dialysis Patients
por: Agur, Timna, et al.
Publicado: (2022) -
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
por: Shashar, Moshe, et al.
Publicado: (2022) -
Cellular and Humoral Responses in Dialysis Patients after Vaccination with the BNT162b2 or mRNA-1273 Vaccines
por: Mavrovouniotis, Ilias, et al.
Publicado: (2023) -
Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis
por: Dekervel, Marine, et al.
Publicado: (2021)